FDA advisory board supports implant that suppresses appetite

06/18/2014 | HealthDay News

An FDA advisory committee on Tuesday said EnteroMedics' Maestro Rechargeable System, designed to suppress appetite and calorie absorption through electrical stimulation of intra-abdominal vagus nerve trunks, is safe and its benefits outweigh the risks. However, the panel was split on whether the device would be effective for patients.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN